Piper Sandler raises Alphatec stock price target to $25 on strong Q3 results
PositiveFinancial Markets

Piper Sandler has raised its price target for Alphatec's stock to $25 following impressive third-quarter results. This adjustment reflects confidence in Alphatec's performance and growth potential, which is significant for investors looking for promising opportunities in the medical technology sector.
— Curated by the World Pulse Now AI Editorial System







